SCHEMBL19669285

SCHEMBL19669285

CCCC(C)(C)COCCN1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
MAPK1 P28482 2/20 0.45
CYP1A2 P05177 1/20 0.45
CHRM2 P08172 1/20 0.45
CHRM1 P11229 1/20 0.45
HTR2A P28223 1/20 0.45
SCN1A P35498 1/20 0.45
HTR2B P41595 1/20 0.45
KCNH2 Q12809 1/20 0.45
SCN2A Q99250 1/20 0.45
SIGMAR1 Q99720 1/20 0.45
SCN3A Q9NY46 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
USP2 O75604 2/20 0.44
LMNA P02545 2/20 0.44
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 2/20 0.41
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667940 0.85 KDM4E (0.40) ALDH1A1CYP1A2HRH3LMNACYP2D6
SCHEMBL11923452 0.81 CYP2D6 (0.44) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL19888347 0.80 SMN1; SMN2 (0.47) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL18909499 0.79 ALDH1A1 (0.47) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL20332899 0.79 TSHR (0.47) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL21791808 0.78 TSHR (0.43) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL23471084 0.78 CYP2D6 (0.42) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL12422516 0.78 CYP3A4 (0.42) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL16019413 0.78 CYP2D6 (0.42) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL3305244 0.77 ALDH1A1 (0.54) ALDH1A1MAPK1CYP1A2CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9834560-B2 Compounds RESPIVERT LTD. (GB) 2017-12-05 US disclosed